![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 16845 | Ordered by Country (descending)
1 2 3 ... 167 168 169 
  Person |
Position |
Organisation (Group) |
 Country |
|---|---|---|---|
| Han, Jason (SGS 201701 Managing Director of SGS Vietnam) | Managing Director | SGS (Group) | Vietnam |
| Minh, Nguyen Thi Hong (Sac Ky Hai Dang Laboratory 201506 Vice Board Chairwoman) | Board member | Eurofins (Group) | Vietnam |
| Abecassis, William (BlackRock 202103 Head of Innovation Capital) | Investment Manager | BlackRock (Group) | United States (USA) |
| Abraham, Robert (Pfizer 201412 SVP + CSO at Onology Research Unit) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Pfizer (Group) | United States (USA) |
| Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) | Chief Medical Officer (CMO) | Editas Medicine Inc. (Nasdaq: EDIT) | United States (USA) |
| Adamis, Anthony P. (Jerini Ophthalmic 200703– CEO) | Chief Executive Officer (CEO) | Takeda (Group) | United States (USA) |
| Adams, Adrian (Auxilium 201112– CEO before Neurologix + Inspire Pharma + Sepracor + Kos + Novartis UK) | Chief Executive Officer (CEO) | Dainippon Sumitomo (Group) | United States (USA) |
| Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) | Chief Executive Officer (CEO) | Pairwise (Group) | United States (USA) |
| Adelman, Burt (Dyax 2012–2016 EVP + CMO before Eleven Biotherapeutics + Biogen) | Board member, non-executive | Takeda (Group) | United States (USA) |
| Adulamy, Maya (Valo Health 202012– Head of Strategic Partnerships based in Israel before at Maccabi) | Business Development Manager / Strategy Manager | Valo Health (Group) | United States (USA) |
| Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) | Chief Executive Officer (CEO) | Flagship Pioneering | United States (USA) |
| Agarwala, Sandip (Blue Owl Capital 202208 Managing Director at Owl Rock) | Managing Director | Blue Owl Capital (Group) | United States (USA) |
| Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) | n. a. | Aureon Laboratories Inc. | United States (USA) |
| Agnus, Jean-Baptiste (JB) (JSR Corp 202404– CBO at KBI Biopharma before AGC Biologics + Ajinomoto Bio-Pharma + Novasep) | Chief Business Officer (CBO) | JSR Corporation (Group) | United States (USA) |
| Aguiar, Michael (Theravance 200601 Senior VP + CFO) | Chief Financial Officer (CFO) | Innoviva (Group) | United States (USA) |
| Agus, David (Ellison Institute for Transformative Medicine 202205 Co-Founder) | Company Founder | Lawrence J. Ellison Institute for Transformative Medicine | United States (USA) |
| Ahlberg, Christopher (Spotfire 200505 CEO) | Chief Executive Officer (CEO) | TIBCO Software (Group) | United States (USA) |
| Ahmadi, Khatereh (Merck (US) 201810 Executive Director Business Development + Licensing) | Business Development Manager / Strategy Manager | Merck (US) (MSD) (Group) | United States (USA) |
| Ahmed, Nadim (BMS 202109 EVP) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
| Ahrens, Brent (Canaan Partners 201603 General Partner) | General Partner (venture partner) | Canaan Partners (Group) | United States (USA) |
| Aitkenhead, Mark (Element Biosciences 202205– Chief Commercial Officer before at Thermo Fisher since 2003) | Chief Commercial Officer (CCO) | Element Biosciences Inc. | United States (USA) |
| Akkaraju, Srinivas (Srini) (Samsara BioCaptial 2016– Founder before Sofinnova Ventures + New Leaf Venture Partners) | Investment Manager | Samsara BioCapital (US) | United States (USA) |
| Al-Wakeel, Yasir (Kronos Bio 202008– CFO + Head of CorpDev before Neon Therapeutics + Merrimack Pharma + Credit Suisse) | Chief Financial Officer (CFO) | Kronos Bio Inc. (Nasdaq: KRON) | United States (USA) |
| Albers, Jeffrey W. (Jeff) (Blueprint Medicinces 201201– President of Algeta US + Genzyme + Mintz Levin) | Chief Executive Officer (CEO) | Blueprint Medicines (Group) | United States (USA) |
| Alessandri, Kévin (TreeFrog Therapeutics 202201– Managing Director TreeFrog Tx Inc before CEO + CTO + Co-Founder) | Chief Executive Officer (CEO) | TreeFrog Therapeutics (Group) | United States (USA) |
| Alexander, Robert (ZS Pharma 201511 CEO) | Chief Executive Officer (CEO) | AstraZeneca (Group) | United States (USA) |
| Alexandre, Leslie (Life Science Washington 202108 CEO) | Chief Executive Officer (CEO) | Life Science Washington | United States (USA) |
| Alexandrova, Natalia (Ariadne Genomics 200605) | n. a. | Reed Elsevier (Group) | United States (USA) |
| Alexanyan, Vladimir (Valtex 1982– Founder) | Company Founder | Valtex (Group) | United States (USA) |
| Allan, Rich (Trout Group 201903) | Public Relations Manager / Investor Relations Manager | PNC Financial Services (Group) | United States (USA) |
| Allen, Rich (PNC Financial Services 202009 at Solebury Trout) | Public Relations Manager / Investor Relations Manager | PNC Financial Services (Group) | United States (USA) |
| Alles, Mark (Celgene 201306 EVP + Global Head Hematology + Oncology) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
| Altshuler, David (Vertex 201510 EVP Global Research + CSO before Broad Institute 200510) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vertex Pharmaceuticals (Group) | United States (USA) |
| Amado, Rafael G. (Allogene 201909– EVP RnD + CMO before Adaptimmune + GSK + Amgen + UCLA) | Chief Medical Officer (CMO) | Allogene Therapeutics Inc. (Nasdaq: ALLO) | United States (USA) |
| Amariglio, Roy (OrbiMed 201605– Principal before Bayer HealthCare) | Principal (venture capital) | OrbiMed (Group) | United States (USA) |
| Amidi, Saeed (Plug and Play 201706 CEO + Founder) | Chief Executive Officer (CEO) | Plug and Play (Group) | United States (USA) |
| Amoroso, Michael (Precision BioSciences 202110– CEO before Abeona Tx + Gilead/Kite + Eisai Inc + Celgene + Sanofi) | Chief Executive Officer (CEO) | Precision BioSciences (Group) | United States (USA) |
| Amsallem, Gilles (Arbiom 201603 CEO before Biométhodes SA CEO) | Chief Executive Officer (CEO) | Arbiom (Group) | United States (USA) |
| Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) | Business Development Manager / Strategy Manager | Bruker (Group) | United States (USA) |
| Ananth, Arun (Proscia 202301 Chief Commercial Officer) | Chief Commercial Officer (CCO) | Proscia Inc. | United States (USA) |
| Ancher-Jensen, Henrik (Agilent 201309– SVP + President of Agilent Order Fulfillment before Dako + Chr Hansen) | President/Director/Head Business Group/Unit/Division | Agilent (Group) | United States (USA) |
| Anderson, Bonnie H. (PinkDx 202404 CEO + Co-Founder before Veracyte 201409 CEO + Co-Founder) | Chief Executive Officer (CEO) | PinkDx Inc. | United States (USA) |
| Anderson, Daniel G. (MIT 201705 + CRISPR Therapeutics Scientific Founder + Advisory Board Member) | Researcher (university / research institute) | MIT (Massachusetts Institute of Technology) | United States (USA) |
| Anderson, David (Ampersand 201905 General Partner) | General Partner (venture partner) | Ampersand (Group) | United States (USA) |
| Anderson, Errik (Biomatics Capital 201811– Venture Partner + Alloy Therapeutics before Adimab + Compass Therapeutics) | Venture Partner | Biomatics Capital Partners (US) | United States (USA) |
| Anderson, Mary L. (Xoma 200803– VP Business Developm before Merck-Serono) | Business Development Manager / Strategy Manager | Xoma (Group) | United States (USA) |
| Anderson, N. Leigh (Plasma Proteome Institute 200808 + SCISCAPA Assay Technologies) | mass spectrometry (MS) | Plasma Proteome Institute (PPI) | United States (USA) |
| Anderson, Steve (LabCorp 201904 CSO at Covance) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | LabCorp (Group) | United States (USA) |
| Anderson, Thomas D. (Tom) (SwanBio Therapeutics 202203 CEO) | Chief Executive Officer (CEO) | SwanBio Therapeutics Inc. | United States (USA) |
| Anderson, Timothy (Tim) (Cowen 201811 Cowen Healthcare Investments) | Investment Manager | Blue Owl Capital (Group) | United States (USA) |
| Andreotti, Lamberto (Bristol-Myers Squibb 200609 Pres) | n. a. | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
| Andrews, Richard (Rick) (Azitra –202010–202105 CEO RETIRED 5/21) | Chief Executive Officer (CEO) | Azitra Inc. | United States (USA) |
| Andrews, Ron A. (Ronnie) (Life Technologies 201202– President Medical Sciences before GE Healthcare + CEO of Clarient) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | United States (USA) |
| Anzalone, Christopher (Arrowhead Research 201503 CEO) | Chief Executive Officer (CEO) | Arrowhead (Group) | United States (USA) |
| Apicerno, Ken (Thermo Fisher 201003 Investor Relations) | Public Relations Manager / Investor Relations Manager | Thermo Fisher (Group) | United States (USA) |
| Apte, Arun (Premier Biosoft 201210 CEO) | Chief Executive Officer (CEO) | Premier Biosoft (Group) | United States (USA) |
| Araya, Arturo (TrakCel 202105– CCO based in US before Brainstorm Cell Therapeutics + Novartis + BMS) | Chief Commercial Officer (CCO) | TrakCel (Group) | United States (USA) |
| Arbogast, Susanne (Roche 201308 Head Innovation + External Affairs at Roche Diagnostics) | Business Development Manager / Strategy Manager | Roche (Group) | United States (USA) |
| Arciero, Michael (ERS Genomics 202009– VP IP + Commercial Development before USC Stevents Center for Innovation) | IP Manager | University of Southern California (USC) | United States (USA) |
| Arcure, Jennifer (Verge Scientific Communications 202102) | Public Relations Manager / Investor Relations Manager | Deerfield Agency (Group) | United States (USA) |
| Armen, Garo H. (Agenus 201402 CEO) | Chief Executive Officer (CEO) | Agenus (Group) | United States (USA) |
| Armento, Alex (MatTek 202103 CEO) | Chief Executive Officer (CEO) | Bico (Group) | United States (USA) |
| Armstrong, Brian (bioMérieux 202203 SVP Clinical Operations North America) | n. a. | Mérieux (Group) | United States (USA) |
| Armstrong, Frank M. (CuraGen 200603 CEO before Bioaccelerate before Provensis before Bayer before Zeneca) | Chief Executive Officer (CEO) | CuraGen (Group) | United States (USA) |
| Armstrong, Robert (Rob) (Boston Pharmaceuticals 201511– CEO before Eli Lilly + Amgen | Chief Executive Officer (CEO) | BERTARELLI Group (family of Ernesto Bertarelli) | United States (USA) |
| Arnold, Drew (Cartagenia 201203– VP Sales + BusDev North America before GenomeQuest/Gene-IT + Lion Bioscience) | Sales Manager / Marketing Manager | Agilent (Group) | United States (USA) |
| Arnold, Lauren (MacDougall Biomedical Communications 201801) | Public Relations Manager / Investor Relations Manager | MacDougall Advisors Inc. | United States (USA) |
| Arnold, Nico (Cepheid 201004 EVP Worldwide Commercial Operations) | Business Manager | Danaher (Group) | United States (USA) |
| Arnot, Christopher (Merck (DE) 202209 Director BusDev + Licensing Gene Editing + Novel Modalities at Sigma-Aldrich) | Business Development Manager / Strategy Manager | Merck (DE) (Group) | United States (USA) |
| Arroyo, Santiago (Boston Pharmaceuticals 201511– CMO before Pfizer + BMS + Eisai) | Chief Medical Officer (CMO) | BERTARELLI Group (family of Ernesto Bertarelli) | United States (USA) |
| Artuso, Anthony (Merck (DE) 201310 VP Strategy + Business Development at EMD Millipore) | Chief Executive Officer (CEO) | Merck (DE) (Group) | United States (USA) |
| Asa, Darwin (HighRes Biosolutions 201511– Marketing Manager before Waters + Bruker Corp + ESA + Tecan) | Sales Manager / Marketing Manager | HighRes Biosolutions Inc. | United States (USA) |
| Asadi, Narges Bani (Bina Technologies 201412 CEO + Founder) | Chief Executive Officer (CEO) | Roche (Group) | United States (USA) |
| Asali, Omar (Ranpak 202110 CEO) | Chief Executive Officer (CEO) | Ranpak (US) | United States (USA) |
| Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) | President/Director/Head Business Group/Unit/Division | Otsuka (Group) | United States (USA) |
| Ashton, Paul (Inflammasome Therapeutics 201909 CEO) | Chief Executive Officer (CEO) | Inflammasome Therapeutics (US) | United States (USA) |
| Asokan, Aravind (Univ of North Carolina at Chapel Hill 201704 + StrideBio Co-Founder) | Researcher (university / research institute) | University of North Carolina | United States (USA) |
| Aspinall, Mara G. (Roche 201109– President Ventana Medical before On-Q-ity founder + CEO before Genzyme) | President/Director/Head Business Group/Unit/Division | LabCorp (Group) | United States (USA) |
| Astriab-Fisher, Anna (Gentel 200611– VP Assay Development before GKS) | Research & Development Manager | Gentel Biosciences Inc. | United States (USA) |
| Atieh, Michael G. (OSI Pharmaceuticals –200812 CFO retired 1/09) | Chief Financial Officer (CFO) | Astellas (Group) | United States (USA) |
| Atlas, Mark (Fluxion 200804 Director Sales) | Sales Manager / Marketing Manager | Fluxion Biosciences Inc. | United States (USA) |
| Audoly, Laurent (Parthenon Therapeutics 201909– CEO + Co-Founder before Kymera Therapeutics + Pierre Fabre + Pieris) | Chief Executive Officer (CEO) | Parthenon Therapeutics (US) | United States (USA) |
| Auspitz, Ben (F-Prime Capital 201708) | n. a. | F-Prime Capital Partners (F-Prime Biosciences) | United States (USA) |
| Austin, Katherine | n. a. | Frost & Sullivan | United States (USA) |
| Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) | Principal (venture capital) | Illumina (Group) | United States (USA) |
| Avery, Michelle (Tome Biosciences 202312 VP Corporate Affairs formerly MacDougall Biomedical Communications 201504) | Public Relations Manager / Investor Relations Manager | MacDougall Advisors Inc. | United States (USA) |
| Axon, Steven (Steve) (Glycomine 202207– CEO before Prothelia + Apellis Pharmaceuticals + Merck KGaA) | Chief Executive Officer (CEO) | Glycomine Inc. | United States (USA) |
| Aylward, Christine (Magnetic Ventures 202206 Managing Partner + Founder) | Managing Partner | Magnetic Ventures (US) | United States (USA) |
| Azam, Usman (Oz) (Tmunity Therapeutics 201612– CEO before Novartis + Novaccel + Aspreva + JnJ) | Chief Executive Officer (CEO) | Gilead Sciences (Group) | United States (USA) |
| Azelby, Robert (Bob) (Eliem Therapeutics 202103 CEO before Alder BioPharmaceuticals + Juno Tx + Amgen) | Chief Commercial Officer (CCO) | Eliem Therapeutics (Group) | United States (USA) |
| Azimi, Nazli (Bioniz Therapeutics 202001 CEO + Founder) | Chief Executive Officer (CEO) | Bioniz Therapeutics Inc. | United States (USA) |
| Aziz, Kabeer (Adjuvant Capital 202105) | Investment Manager | Adjuvant Capital LLC | United States (USA) |
| Azzam, Fouad (Life Sciences Partners 201509 Partner at US Office of LSP) | Partner (venture partner) | EQT (Wallenberg family) (Group) | United States (USA) |
| Babbush, Ryan (Alphabet 202101 Head of Quantum Algorithms at Google Quantum AI) | n. a. | Alphabet (formerly Google) (Group) | United States (USA) |
| Babe, Greg (Bayer Corp 200807– CEO before CEO Bayer MaterialScience) | Chief Executive Officer (CEO) | Bayer (Group) | United States (USA) |
| Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome) | Chief Executive Officer (CEO) | Gotham Therapeutics (Group) | United States (USA) |
| Babitt, John (Ernst & Young 201511 Medical Technology Leader for the Americas) | Consultant (economic/technology) | Ernst & Young (Group) | United States (USA) |
| Babler, Martin (Principia Biopharma 202008 CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | United States (USA) |
| Bader, Bret (Advance Nanotech 200906 CEO of Owlstone Nanotech Inc) | Chief Executive Officer (CEO) | Owlstone (Group) | United States (USA) |
| Baier, Manfred (Roche –201112 RETIRES 12/11 as head of Roche Applied Science) | President/Director/Head Business Group/Unit/Division | Roche (Group) | United States (USA) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
